[Substitution treatments. Pharmacological and legislative aspects].
Bouchez
J
J
Clinique Liberté, Emmanuel Khan-Shaghaghi, Villejuif.
Khan-Shaghaghi
E
E
Beauverie
P
P
Poisson
N
N
D002047:Buprenorphine / Q000627:therapeutic use*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D005602:France; D006801:Humans; D008691:Methadone / Q000627:therapeutic use*; D009294:Narcotics / Q000627:therapeutic use*; D011634:Public Health; D016320:Substance Abuse Treatment Centers / Q000458:organization & administration*; D019966:Substance-Related Disorders / Q000188:drug therapy*
D009294:Narcotics; D002047:Buprenorphine; D008691:Methadone